CY1121916T1 - Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα - Google Patents

Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα

Info

Publication number
CY1121916T1
CY1121916T1 CY20191100896T CY191100896T CY1121916T1 CY 1121916 T1 CY1121916 T1 CY 1121916T1 CY 20191100896 T CY20191100896 T CY 20191100896T CY 191100896 T CY191100896 T CY 191100896T CY 1121916 T1 CY1121916 T1 CY 1121916T1
Authority
CY
Cyprus
Prior art keywords
lung tumor
risk
diagnosis
micro
identification
Prior art date
Application number
CY20191100896T
Other languages
English (en)
Inventor
Gabriella Sozzi
Ugo PASTORINO
Mattia BOERI
Original Assignee
Gabriella Sozzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI2011A000172A external-priority patent/IT1406672B1/it
Priority claimed from ITMI2011A000174A external-priority patent/IT1406866B1/it
Priority claimed from ITMI2011A000173A external-priority patent/IT1403685B1/it
Application filed by Gabriella Sozzi filed Critical Gabriella Sozzi
Publication of CY1121916T1 publication Critical patent/CY1121916T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Μια διαδικασία και μια συσκευή περιγράφονται για την ταυτοποίηση ατόμων που κινδυνεύουν από πνευμονικό όγκο και / ή για τη διάγνωση πνευμονικού όγκου χρησιμοποιώντας τη μελέτη των επιπέδων έκφρασης του miRNA στο αίμα ή σε άλλο βιολογικό υγρό. Περιγράφεται επίσης μια μέθοδος και μια ένωση για τη μείωση ή την εξάλειψη του κινδύνου του πνευμονικού όγκου με την επανεξισορρόπηση των miRNA που υποεκφράζονται ή υπερεκφράζονται.
CY20191100896T 2011-02-07 2019-08-21 Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα CY1121916T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI2011A000172A IT1406672B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonche' composizione e metodo per ridurre o eliminare il rischio di tumore polmonare.
ITMI2011A000174A IT1406866B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonché composizione e metodo per ridurre o eliminare il rischio di tumore polmonare
ITMI2011A000173A IT1403685B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonche' composizione e metodo per ridurre o eliminare il rischio di tumore polmonare.
US201161522328P 2011-08-11 2011-08-11
PCT/IB2012/000567 WO2012107841A2 (en) 2011-02-07 2012-02-07 Micro-rna biomarkers and methods of using same

Publications (1)

Publication Number Publication Date
CY1121916T1 true CY1121916T1 (el) 2020-10-14

Family

ID=46062629

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100896T CY1121916T1 (el) 2011-02-07 2019-08-21 Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα

Country Status (16)

Country Link
US (4) US20120225925A1 (el)
EP (1) EP2734636B1 (el)
AU (2) AU2012215105B2 (el)
BR (1) BR112014003877A2 (el)
CA (1) CA2844596A1 (el)
CY (1) CY1121916T1 (el)
DK (1) DK2734636T3 (el)
ES (1) ES2742840T3 (el)
HK (1) HK1197274A1 (el)
HR (1) HRP20191481T1 (el)
HU (1) HUE045731T2 (el)
IL (1) IL230896B (el)
PL (1) PL2734636T3 (el)
PT (1) PT2734636T (el)
RS (1) RS59161B1 (el)
WO (1) WO2012107841A2 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012107841A2 (en) 2011-02-07 2012-08-16 Biomirna Holdings Ltd. Micro-rna biomarkers and methods of using same
US10011873B2 (en) 2012-11-16 2018-07-03 Universitat Des Saarlandes Diagnostic miRNA markers for Parkinson disease
EP2733219B1 (en) * 2012-11-16 2017-09-20 Siemens Aktiengesellschaft Diagnostic miRNA markers for Alzheimer
CA2935789A1 (en) * 2014-01-05 2015-07-09 Biomirna Holdings Ltd. Lung cancer determinations using mirna
WO2015117205A1 (en) * 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
US20160068913A1 (en) * 2014-09-09 2016-03-10 Istituto Europeo Di Oncologia S.R.L. Methods for Lung Cancer Detection
WO2016049429A1 (en) * 2014-09-26 2016-03-31 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Microrna biomarkers for posttraumatic stress disorder and methods of use thereof
US20160108405A1 (en) * 2014-10-17 2016-04-21 Biomirna Holdings Ltd Lung cancer diagnostics and therapeutics with mir-660
TWI626314B (zh) * 2015-01-09 2018-06-11 長庚大學 評估罹患大腸直腸癌風險的方法
TWI571514B (zh) * 2015-01-09 2017-02-21 長庚大學 評估罹患大腸直腸癌風險的方法
US11535895B2 (en) 2017-04-06 2022-12-27 University Of Maryland, Baltimore Methods of detecting lung cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2534300T3 (es) * 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
EP2502630B1 (en) * 2006-01-05 2015-03-11 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
ES2527592T3 (es) * 2006-01-05 2015-01-27 The Ohio State University Research Foundation Métodos basados en microARN para el diagnóstico del cáncer de colon
US8207325B2 (en) * 2006-04-03 2012-06-26 Univ. of Copenhagen MicroRNA biomarkers for human breast and lung cancer
EP2198050A1 (en) * 2007-09-14 2010-06-23 Asuragen, INC. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009052386A1 (en) * 2007-10-18 2009-04-23 Asuragen, Inc. Micrornas differentially expressed in lung diseases and uses thereof
CN101918594A (zh) 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
WO2009147525A1 (en) * 2008-06-04 2009-12-10 Karolinska Institutet Innovations Ab Skin cancer associated micrornas
CN102549166A (zh) * 2009-02-26 2012-07-04 俄亥俄州立大学研究基金会 从未吸烟者中的MicroRNA及相关材料和方法
EP2341145A1 (en) * 2009-12-30 2011-07-06 febit holding GmbH miRNA fingerprint in the diagnosis of diseases
EP2354246A1 (en) * 2010-02-05 2011-08-10 febit holding GmbH miRNA in the diagnosis of ovarian cancer
CN101804208A (zh) * 2010-02-26 2010-08-18 南京医科大学 miR-451在制备治疗非小细胞肺癌药物的应用
WO2012107841A2 (en) 2011-02-07 2012-08-16 Biomirna Holdings Ltd. Micro-rna biomarkers and methods of using same

Also Published As

Publication number Publication date
US20150045233A1 (en) 2015-02-12
IL230896A0 (en) 2014-03-31
US9926603B2 (en) 2018-03-27
WO2012107841A2 (en) 2012-08-16
ES2742840T3 (es) 2020-02-17
DK2734636T3 (da) 2019-08-26
US20210130905A1 (en) 2021-05-06
HK1197274A1 (en) 2015-01-09
WO2012107841A3 (en) 2013-01-17
CA2844596A1 (en) 2012-08-16
HUE045731T2 (hu) 2020-01-28
HRP20191481T1 (hr) 2019-11-15
US20120225925A1 (en) 2012-09-06
EP2734636A2 (en) 2014-05-28
IL230896B (en) 2019-10-31
AU2012215105B2 (en) 2017-05-11
US20190062843A1 (en) 2019-02-28
AU2012215105A1 (en) 2014-06-05
PT2734636T (pt) 2019-09-06
EP2734636B1 (en) 2019-05-22
PL2734636T3 (pl) 2019-10-31
RS59161B1 (sr) 2019-10-31
BR112014003877A2 (pt) 2017-06-13
AU2017213457B2 (en) 2019-08-29
AU2017213457A1 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
CY1121916T1 (el) Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
BR112016029583A2 (pt) ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção?
CY1122185T1 (el) Ιατρικη χρηση ενωσεων αρτεμισινινης και αγωνιστων γεφυρινης
EP3744859A3 (en) Microrna biomarker for the diagnosis of gastric cancer
BR112017018008A2 (pt) ?métodos de prognóstico e/ou diagnóstico do câncer, para determinação da dosagem de um produto, para adaptar a dosagem de um produto, para determinar os efeitos benéficos e/ou adversos de uma substância, para identificar um paciente como respondedor a um tratamento, para identificar um paciente como não respondedor a um tratamento, para tratar o câncer, meios para prognosticar e/ou diagnosticar, kit, uso dos meios e dispositivo para a identificação de câncer?
BR112015011359A2 (pt) método para indicar uma presença ou não presença de câncer de próstata agressivo
EP3236262A3 (en) Surrogate functional diagnostics test for cancer
MX364410B (es) Metodo para detectar nucleosomas que contienen nucleotidos.
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
CY1123172T1 (el) Δοκιμασια για συλληψη και ανιχνευση κυκλοφορουντων κυτταρων πολλαπλου μυελωματος απο αιμα
WO2013172779A3 (en) Method for indicating the presence or non-presence of prostate cancer
EP2619587A4 (en) BIOMARKERS FOR RECURRENCE PREDICTION OF COLORECTAL CANCER
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
EA201401201A1 (ru) Способ
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido
MX369763B (es) Sistemas y metodos de codificacion para la calibracion de biosensores.
MX369911B (es) Método basado en expresión génica para clasificar pacientes con cãncer de riñón de acuerdo al riesgo de recurrencia.
MX2016012278A (es) Deteccion temprana de preeclampsia.
PH12015500388A1 (en) Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells
WO2015006657A3 (en) Method for the diagnosis and prognosis of cancer
WO2015115923A3 (en) A profile of microrna in the blood as a test for the detection of lung cancer
WO2014146035A3 (en) Compositions and methods for cancer diagnosis
AR085164A1 (es) Metodos para el analisis de la placa
BR112014028659A2 (pt) métodos de diagnóstico de câncer, erlotinib, usos de um autoanticorpo, kits e invenção